The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
By Stephen L. Hauser, Jorge R. Oksenberg. Neuron, 2006
805 citations recorded by the source corpus.
Subfields: Immunology, Neurology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/afab5e3aeaf3f6ad4e5b6204290d20052576d0a4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
In Pathology and Forensic Medicine
Citations in the corpus
- A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis (2011, background): “2324" language="eng" relation="no"> In multiple sclerosis, a common inflammatory disease of the central nervous system, immune-mediated axon damage is responsible for permanent neurological deficit”
- Defining the Role of the MHC in Autoimmunity: A Review and Pooled Analysis (2008, neutral): “gov/sites/entrez?db= omim] accession number [MIM] 126200) is a chronic inflammatory demyelinating disorder of the central nervous system (reviewed in [13,14]).”
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial (2009, background): “The remaining MS patients present with gradually increasing neurological disability, primarily affecting ambulation, without discernable relapses; this type, primary progressive MS (PPMS), has a mean age of onset a decade later than RRMS.(1,3) To date, there are no proven disease-modifying treatment”